Nantahala Capital Management »

Recro Pharma shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Recro Pharma (SCTL) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Recro Pharma

Tip: Access up to 7 years of quarterly data

All positions including Recro Pharma held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recro Pharma by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $426k 1.2M 0.35
2023-09-30 $586k 1.3M 0.47

More positions owned by Nantahala Capital Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Russell 2000 Etf (IWM)
Soleno Therapeutics (SLNO)
Soleno Therapeutics (SLNO)
Establishment Labs Holdings Ord (ESTA)
Establishment Labs Holdings Ord (ESTA)
Meta Financial (CASH)
Meta Financial (CASH)
Costco Wholesale Corporation Put Option (COST)
Costco Wholesale Corporation Put Option (COST)
Imax Corp Cad (IMAX)
Imax Corp Cad (IMAX)
Hilton Grand Vacations (HGV)

View all positions for Nantahala Capital Management

Top funds holding Recro Pharma

First Light Asset Management
AWM Investment Company
Royce & Associates
Samjo Management
Vanguard Group
OV Management
Caligan Partners
First Eagle Investment Management
Alyeska Investment Group
Nantahala Capital Management
Clear Harbor Asset Management
Titleist Asset Management
Citadel Advisors
Millennium Management
Global Retirement Partners

View all funds holding Recro Pharma